Daegu, South Korea

Chang Hoon Seo

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Pimedbio, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang Hoon Seo. Retrieved from https://idiyas.com/inventor/chang-hoon-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chang Hoon Seo: Innovator in Pharmaceutical Applications

Introduction

Chang Hoon Seo is an inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for mental health treatment. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.

Latest Patent Applications

Chang Hoon Seo has submitted several patent applications that showcase his innovative approach. One of his latest applications is for a carboxamide derivative and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating mental illness. This derivative is highly effective as a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, making it a promising candidate for mental health therapies. Another application focuses on a novel compound and its preparation method, which involves creating a biomaterial with selectively functionalized tyrosine. This method allows for high-yield coupling of the compound to tyrosine, ensuring that the inherent activity of the biomaterial is maintained.

Conclusion

Chang Hoon Seo's innovative work in pharmaceutical applications highlights his potential as a significant contributor to the field. His latest patent applications reflect a commitment to advancing treatments for mental illness and improving biomaterials.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…